Flower, M., Lomeikaite, V., Ciosi, M., Cumming, S., Morales Montero, F., Lo, K., . . . Tabrizi, S. J. (2019). MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1.
Chicago Style CitationFlower, Michael, et al. MSH3 Modifies Somatic Instability and Disease Severity in Huntington’s and Myotonic Dystrophy Type 1. 2019.
Cita MLAFlower, Michael, et al. MSH3 Modifies Somatic Instability and Disease Severity in Huntington’s and Myotonic Dystrophy Type 1. 2019.
Atenció: Aquestes cites poden no estar 100% correctes.